Koc Holding Acquires 65% of Stembio
Deal News | Nov 28, 2024 | CEE Legal Matters
Koc Holding, a prominent conglomerate in Turkey, has acquired a 65% stake in the biotechnology company Stembio. The transaction was facilitated by legal advisors Sadik & Capan, representing Koc Holding, and Acar Ergonen, representing the seller, Ibrahim Ozsu. This strategic acquisition marks an important step for Koc Holding in expanding its footprint in the biotechnology sector. The team from Sadik & Capan included Managing Partners Serra Sadik Hiziroglu and Nazli Tonuk Capan, along with Associate Seda Koprulu. Meanwhile, Acar Ergonen's team comprised Managing Partner Duygu Acar Yucesoy, Partner Asli Tezcan, and Associates Sena Yerli and Sila Eyvaz Sir.
Sectors
- Biotechnology
Geography
- Turkey – This acquisition involves Turkish companies and legal advisors, reflecting significant investment activity within Turkey.
Industry
- Biotechnology – Stembio operates within the biotechnology sector, focusing on advanced biological products and technologies.
Financials
- 65% – The stake acquired by Koc Holding in Stembio.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Koc Holding | Acquirer | Company | A major Turkish conglomerate expanding into biotechnology. |
| Stembio | Target | Company | A biotechnology company based in Turkey. |
| Ibrahim Ozsu | Seller | Person | The seller of the 65% stake in Stembio. |
| Sadik & Capan | Legal Advisor for Acquirer | Company | Legal firm advising Koc Holding on the acquisition. |
| Acar Ergonen | Legal Advisor for Seller | Company | Legal firm advising Ibrahim Ozsu on the sale of Stembio shares. |